China Biologic Products to Present at the Rodman & Renshaw Annual China Investment Conference

News provided by

China Biologic Products, Inc.

Mar 03, 2010, 08:00 ET

TAI'AN, China, March 3 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that the Company's management team will present at the Rodman & Renshaw Annual China Investment Conference March 7 to 9, 2010 in Beijing, China.

The date, time and location of China Biologic's presentation at the Rodman & Renshaw Annual China Investment Conference are as follows:

    Date:      Monday, March 8, 2010
    Time:      10:15 a.m. to 10:40 a.m.
    Presenter: Mr. Chaoming Zhao, Chief Executive Officer
               Mr. Ming Yin, VP of Finance and Investor Relations
    Venue:     The Regent Hotel - Ball Room III
               No. 99 Jinbao Street, Dongcheng District
               Beijing 100005, China

During the conference, management will be available for one-on-one meetings with institutional investors. Interested parties please contact Lily Khaykina at [email protected] or (212) 430-1714. Participation in the R&R Conference is by invitation only.

About China Biologic Products, Inc.

China Biologic Products, Inc. (the "Company"), through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd, and its equity investment in Xi'an Huitian Blood Products Co., Ltd., is currently the largest non-state-owned plasma-based biopharmaceutical company in China. The Company is a fully integrated biologic products company with plasma collection, production and manufacturing, research and development, and commercial operations. The Company's plasma-based biopharmaceutical products are irreplaceable during medical emergencies, and are used for the prevention and treatment of various diseases. The Company sells its products to hospitals and other healthcare facilities in China.

    For more information, please contact:

    Company Contact:
     Mr. Y. Tristan Kuo
     Chief Financial Officer
     China Biologic Products, Inc.
     Tel:   +86-538-6202206
     Email: [email protected]
     Web:   http://www.chinabiologic.com

     Investor Relations Contact:
     Ms. Lei Huang, Account Manager
     CCG Investor Relations
     Tel:   +1-646-833-3417
     Email: [email protected]
     Web:   http://www.ccgirasia.com

     Mr. Crocker Coulson, President
     Tel:   +1-646-213-1915
     Email: [email protected]

SOURCE China Biologic Products, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED